{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:05:57Z","timestamp":1789679157742,"version":"4.0.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1-HL-108867 (Z.K.)"],"award-info":[{"award-number":["RO1-HL-108867 (Z.K.)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SC1GM128210 (S.J.)"],"award-info":[{"award-number":["SC1GM128210 (S.J.)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00318","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T04:22:14Z","timestamp":1523420534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Caitlin","family":"Schafer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabzali","family":"Javadov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne F.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Glukhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold W.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaza","family":"Khuchua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1074\/jbc.M110.171439","article-title":"Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.","volume":"286","author":"Acehan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature20111","article-title":"Evolution of Osteocrin as an activity-regulated factor in the primate brain.","volume":"539","author":"Ataman","year":"2016","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"H749","DOI":"10.1152\/ajpheart.00414.2014","article-title":"The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARalpha-cyclophilin D interaction in cardiomyocytes.","volume":"308","author":"Barreto-Torres","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9282087","article-title":"Possible role of interaction between PPARalpha and cyclophilin d in cardioprotection of AMPK against In Vivo ischemia-reperfusion in rats.","volume":"2016","author":"Barreto-Torres","year":"2016","journal-title":"PPAR Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.3390\/ijms13067694","article-title":"The role of PPARalpha in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia\/reperfusion in rats.","volume":"13","author":"Barreto-Torres","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.jmb.2013.05.010","article-title":"Molecular mechanism of peroxisome proliferator-activated receptor alpha activation by WY14643: a new mode of ligand recognition and receptor stabilization.","volume":"425","author":"Bernardes","year":"2013","journal-title":"J. Mol. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FJC.0b013e3180544540","article-title":"The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.","volume":"49","author":"Brigadeau","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"H719","DOI":"10.1152\/ajpheart.00394.2008","article-title":"PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase\/Akt and NO pathway.","volume":"296","author":"Bulhak","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization.","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1242\/dev.143354","article-title":"Osteocrin, a peptide secreted from the heart and other tissues, contributes to cranial osteogenesis and chondrogenesis in zebrafish.","volume":"144","author":"Chiba","year":"2016","journal-title":"Development"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome.","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044335","article-title":"Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse.","volume":"7","author":"Dillon","year":"2012","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10545-008-0844-847","article-title":"PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.","volume":"31","author":"Djouadi","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-beta signaling in cardiac remodeling.","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1093\/hmg\/dds355","article-title":"Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.","volume":"21","author":"Dumont","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbalip.2007.05.003","article-title":"PPARalpha and dyslipidemia.","volume":"1771","author":"Duval","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"B17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cmet.2012.12.012","article-title":"Exercise metabolism and the molecular regulation of skeletal muscle adaptation.","volume":"17","author":"Egan","year":"2013","journal-title":"Cell Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature13236","article-title":"Quantitative flux analysis reveals folate-dependent NADPH production.","volume":"510","author":"Fan","year":"2014","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/CIRCRESAHA.113.259259","article-title":"Essential and unexpected role of Yin Yang 1 to promote mesodermal cardiac differentiation.","volume":"112","author":"Gregoire","year":"2013","journal-title":"Circ. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.beem.2007.09.004","article-title":"PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.","volume":"21","author":"Gross","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128561","article-title":"Cardiac metabolic pathways affected in the mouse model of Barth syndrome.","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0605-5","article-title":"The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome.","volume":"12","author":"Huang","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","article-title":"Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington\u2019s disease.","volume":"21","author":"Johri","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B24","doi-asserted-by":"crossref","first-page":"iii68","DOI":"10.1136\/ard.60.90003.iii68","article-title":"The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages.","author":"Kiemer","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/CIRCRESAHA.117.306585","article-title":"Activating PPARalpha prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.","volume":"117","author":"Lam","year":"2015","journal-title":"Circ. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1139\/H07-082","article-title":"Exercise and MEF2-HDAC interactions.","volume":"32","author":"McGee","year":"2007","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1113\/jphysiol.2009.181065","article-title":"Exercise-induced histone modifications in human skeletal muscle.","author":"McGee","year":"2009","journal-title":"J. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/CIRCRESAHA.117.312624","article-title":"A new secretory peptide of natriuretic peptide family, osteocrin, suppresses the progression of congestive heart failure after myocardial infarction.","volume":"122","author":"Miyazaki","year":"2018","journal-title":"Circ. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"36454","DOI":"10.1074\/jbc.M708596200","article-title":"Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth.","volume":"282","author":"Moffatt","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"26089","DOI":"10.1074\/jbc.M203997200","article-title":"Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.","volume":"227","author":"Muoio","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1124\/mol.108.052928","article-title":"Bezafibrate at clinically relevant doses decreases serum\/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.","volume":"75","author":"Nakajima","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure.","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.mito.2012.12.003","article-title":"Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy.","volume":"13","author":"Noe","year":"2013","journal-title":"Mitochondrion"},{"key":"B34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","article-title":"Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.","volume":"82","author":"Orngreen","year":"","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10545-014-9779-9773","article-title":"No effect of bezafibrate in patients with CPTII and VLCAD deficiencies.","volume":"38","author":"Orngreen","year":"","journal-title":"J. Inherit. Metab. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1388-1981(03)00065-9","article-title":"Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null mice.","volume":"1632","author":"Peters","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00074","article-title":"Diminished exercise capacity and mitochondrial bc1 complex deficiency in tafazzin-knockdown mice.","volume":"4","author":"Powers","year":"2013","journal-title":"Front. Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4137\/GRSB.S13204","article-title":"Pathway analysis of ChIP-Seq-Based NRF1 target genes suggests a logical hypothesis of their involvement in the pathogenesis of neurodegenerative diseases.","volume":"7","author":"Satoh","year":"2013","journal-title":"Gene Regul. Syst. Bio."},{"key":"B39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2006.10.003","article-title":"PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes.","volume":"4","author":"Schuler","year":"2006","journal-title":"Cell Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.gdata.2014.11.009","article-title":"Whole transcriptome RNA sequencing data from blood leukocytes derived from Parkinson\u2019s disease patients prior to and following deep brain stimulation treatment.","volume":"3","author":"Soreq","year":"2015","journal-title":"Genom. Data"},{"key":"B41","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1089\/hum.2010.199","article-title":"Characterization of a transgenic short hairpin RNA induced murine model of tafazzin deficiency.","volume":"22","author":"Soustek","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"H2122","DOI":"10.1152\/ajpheart.00479.2010","article-title":"Impaired cardiac reserve and severely diminished skeletal muscle O2 utilization mediate exercise intolerance in Barth syndrome.","volume":"301","author":"Spencer","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"16042","DOI":"10.1073\/pnas.1514250112","article-title":"Musclin is an activity-stimulated myokine that enhances physical endurance.","volume":"112","author":"Subbotina","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"31233","DOI":"10.1074\/jbc.M301917200","article-title":"Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter.","volume":"278","author":"Sucharov","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-1106","article-title":"Transcriptomic signatures of peroxisome proliferator-activated receptor alpha (PPARalpha) in different mouse liver models identify novel aspects of its biology.","volume":"15","author":"Szalowska","year":"2014","journal-title":"BMC Genomics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/archinte.165.10.1154","article-title":"Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome.","volume":"165","author":"Tenenbaum","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.neo.2016.09.004","article-title":"Metabolic alterations caused by KRAS mutations in colorectal cancer contribute to cell adaptation to glutamine depletion by upregulation of asparagine synthetase.","volume":"18","author":"Toda","year":"2016","journal-title":"Neoplasia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1023\/B:PHAM.0000041444.06122.8d","article-title":"Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future.","volume":"21","author":"van Raalte","year":"2004","journal-title":"Pharm. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymgme.2012.07.004","article-title":"Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay.","volume":"107","author":"Yamaguchi","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/hmg\/ddr482","article-title":"Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice.","volume":"21","author":"Yatsuga","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","article-title":"Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion.","volume":"56","author":"Zhang","year":"2014","journal-title":"Mol. Cell"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T15:38:11Z","timestamp":1751557091000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":52,"alternative-id":["10.3389\/fphar.2018.00318"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00318","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]},"article-number":"318"}}